FDA lifts Boston Scientific's product approval ban

Recent Outbreaks Posted on

Boston Scientific said Wednesday the Food and Drug Administration has lifted some restrictions imposed more than two years due to quality control problems.

In 2006 the FDA issued the company a rare "corporate warning letter," which barred the approval of significant new products. Boston Scientific Chief Executive Jim Tobin said the agency has lifted the ban on product approvals. The formal letter remains in place due to issues surrounding the company's reporting of complaints and malfunctions of its devices.

Tobin told analysts on an earnings call that the company was actively working to resolve those issues.

Many analysts had previously suggested the company was making progress toward resolving FDA's complaints. Earlier this month FDA approved the company's next-generation Taxus Liberte stent, which was launched in Europe in 2005 but had been delayed by the warning letter.

Legal News Media

Legal News is the top headline legal news provider for lawyers and legalprofessionals. Read law articles and breaking news from law firm's across the United States to get the latest updates. We reserve the right, at our discretion, to change, modify, add, or remove portions of the site at any time. Your This site is solely for your personal use. You are, of course, welcome to print or otherwise copy material from this site for your personal use. However, you may not distribute, exchange, modify, sell or transmit anything you copy from this Site, including but not limited to any text, images, audio and video, for any business, commercial or public purpose. Any unauthorized use of the text, images, audio and video may violate copyright laws, trademark laws, the laws of privacy and publicity and civil and criminal statutes.

 

American Bar Association – Start and Run a Law Firm

NewYorkStateBar.com – Starting a Law Firm

Lawyer Website Designs